Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium

Rolando Cannalire, Diana Machado, Tommaso Felicetti, Sofia Santos Costa, Serena Massari, Giuseppe Manfroni, Maria Letizia Barreca, Oriana Tabarrini, Isabel Couto, Miguel Viveiros, Stefano Sabatini, Violetta Cecchetti

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Mycobacterium avium is a difficult-to-treat pathogen able to quickly develop drug resistance. Like for other microbial species, overexpression of efflux pumps is one of the main mechanisms in developing multidrug resistance. Although the use of efflux pumps inhibitors (EPIs) represents a promising strategy to reverse resistance, to date few M. avium EPIs are known. Recently, we showed that in-house 2-phenylquinoline S. aureus NorA EPIs exhibited also a good activity against M. avium efflux pumps. Herein, we report a series of 3-phenylquinolones designed by modifying the isoflavone biochanin A, a natural EPI of the related M. smegmatis, taking into account some important SAR information obtained around the 2-phenylquinoline NorA EPIs. The 3-phenylquinolones inhibited M. avium efflux pumps with derivatives 1e and 1g that displayed the highest synergistic activity against all the strains considered in the study, bringing down (from 4- to 128-fold reduction) the MIC values of macrolides and fluoroquinolones.

Original languageEnglish
Pages (from-to)321-330
Number of pages10
JournalEuropean Journal of Medicinal Chemistry
Volume140
DOIs
Publication statusPublished - 10 Nov 2017

Keywords

  • 3-Phenylquinolones
  • Antimicrobial resistance
  • Efflux pump inhibitors
  • M. avium complex
  • Nontuberculous mycobacteria

Fingerprint

Dive into the research topics of 'Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium'. Together they form a unique fingerprint.

Cite this